Imperial College London
- Country
- 🇧🇪Belgium
- Ownership
- Private
- Established
- 1907-07-08
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.imperial.ac.uk
Inhaled Corticosteroids on Airway Smooth Muscle in Asthma
- First Posted Date
- 2008-04-21
- Last Posted Date
- 2019-09-13
- Lead Sponsor
- Imperial College London
- Registration Number
- NCT00661973
- Locations
- 🇬🇧
Asthma lab, Royal Brompton Hospital, Sydney Street, London, United Kingdom
Prednisolone Pharmacokinetics in Severe Asthma
- First Posted Date
- 2008-04-21
- Last Posted Date
- 2019-11-20
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 5
- Registration Number
- NCT00662298
- Locations
- 🇬🇧
Asthma Laboratory, Royal Brompton Hospital, London, United Kingdom
Modulation of Lung Injury Complicating Lung Resection
- First Posted Date
- 2008-04-10
- Last Posted Date
- 2020-02-05
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 52
- Registration Number
- NCT00655928
- Locations
- 🇬🇧
Royal Brompton Hospital, London, United Kingdom
Genomic/ Proteomic/ Metabonomic Profiling in Chronic Obstructive Pulmonary Disease (COPD)
- Conditions
- Pulmonary Disease, Chronic Obstructive
- First Posted Date
- 2008-04-10
- Last Posted Date
- 2019-07-10
- Lead Sponsor
- Imperial College London
- Registration Number
- NCT00655694
- Locations
- 🇬🇧
National Heart and Lung Institute, London, United Kingdom
A Phase I/II Safety and Tolerability Dose Escalation Study of Autologous Stem Cells to Patients With Liver Insufficiency
- Conditions
- Liver Disease
- Interventions
- Biological: Autologous Expanded CD34+ Haemopoietic cells
- First Posted Date
- 2008-04-10
- Last Posted Date
- 2019-10-31
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 5
- Registration Number
- NCT00655707
- Locations
- 🇬🇧
Imperial College Healthcare Trust, London, United Kingdom
Osteoprotegerin (OPG) in Induced Chronic Obstructive Pulmonary Disease (COPD) Sputum
- Conditions
- Pulmonary Disease, Chronic Obstructive
- Interventions
- Procedure: Induced sputum
- First Posted Date
- 2008-04-10
- Last Posted Date
- 2019-07-10
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 72
- Registration Number
- NCT00655954
- Locations
- 🇬🇧
National Heart and Lung Institute, London, United Kingdom
Melatonin As A Novel Neuroprotectant In Preterm Infants- Dosage Study
- First Posted Date
- 2008-04-01
- Last Posted Date
- 2019-08-20
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 18
- Registration Number
- NCT00649961
- Locations
- 🇬🇧
Imperial College Healthcare NHS Trust, London, United Kingdom
🇬🇧Royal Bolton Hospital, Bolton, United Kingdom
Investigation of Simvastatin in Secondary Progressive Multiple Sclerosis
- Conditions
- Secondary Progressive Multiple Sclerosis
- Interventions
- Drug: Placebo
- First Posted Date
- 2008-03-31
- Last Posted Date
- 2019-12-12
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 140
- Registration Number
- NCT00647348
- Locations
- 🇬🇧
MRI Unit, National Society for Epilepsy, Chesham Lane, Chalfont St. Peter, Buckinghamshire, United Kingdom
🇬🇧Charing Cross Hospital, Fulham Palace Road, Hammersmith, London, United Kingdom
🇬🇧Brighton & Sussex University Hospitals NHS Trust, Eastern Road, Brighton, United Kingdom
Long Term Therapy With Imatinib: Development of Late Side Effects and Compliance to Treatment
- First Posted Date
- 2008-03-10
- Last Posted Date
- 2019-07-08
- Lead Sponsor
- Imperial College London
- Target Recruit Count
- 88
- Registration Number
- NCT00632255
- Locations
- 🇬🇧
Haematology Department. Catherine Lewis Centre. Hammersmith Hospital. Du Cane Road., London, United Kingdom
Stem Cells and Tibial Fractures
- Conditions
- Tibial Fractures
- Interventions
- Other: CD34+ haemopoietic stem cells
- First Posted Date
- 2008-03-10
- Last Posted Date
- 2019-07-15
- Lead Sponsor
- Imperial College London
- Registration Number
- NCT00632034
- Locations
- 🇬🇧
Charing Cross Hospital, London, United Kingdom